{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:13:13Z","timestamp":1786990393080,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024A1515013282"],"award-info":[{"award-number":["2024A1515013282"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572926"],"award-info":[{"award-number":["81572926"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703349"],"award-info":[{"award-number":["81703349"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijbiomac.2026.152742","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:51:37Z","timestamp":1779897097000},"page":"152742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Targeting the EGFR G-quadruplex DNA in liver cancer: Discovery of alkynyl-modified phenanthroimidazole derivatives as potent stabilizers"],"prefix":"10.1016","volume":"369","author":[{"given":"Wanqi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangbo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renshan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152742_bb0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-021-01328-4","article-title":"G-quadruplexes: a promising target for cancer therapy","volume":"20","author":"Kosiol","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152742_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111469","article-title":"Small molecule as potent liver cancer progression inhibitor through stabilizing G-quadruplex DNA to activate replication stress responded DNA damage","volume":"412","author":"Huang","year":"2025","journal-title":"Chem. Biol. Interact."},{"issue":"Pt 3","key":"10.1016\/j.ijbiomac.2026.152742_bb0015","article-title":"Oncogenic and telomeric G-quadruplexes: targets for porphyrin-triphenylphosphonium conjugates","volume":"277","author":"Moura","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.152742_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111550","article-title":"G-quadruplex stabilization via small-molecules as a potential anticancer strategy","volume":"139","author":"Awadasseid","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152742_bb0025","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1038\/s41467-019-11283-w","article-title":"Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to berberine and coptisine","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.152742_bb0030","doi-asserted-by":"crossref","first-page":"10132","DOI":"10.1093\/nar\/gkx678","article-title":"Coexistence of two main folded G-quadruplexes within a single G-rich domain in the EGFR promoter","volume":"45","author":"Greco","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.152742_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113523","article-title":"Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy","volume":"221","author":"Ayati","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152742_bb0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7826","key":"10.1016\/j.ijbiomac.2026.152742_bb0045","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/d41586-020-02673-y","article-title":"Precision oncology","volume":"585","author":"Hodson","year":"2020","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.152742_bb0050","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1158\/2159-8290.CD-24-1476","article-title":"Precision oncology: 2024 in review","volume":"14","author":"Repetto","year":"2024","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152742_bb0055","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1124\/pharmrev.123.001028","article-title":"The art of finding the right drug target: emerging methods and strategies","volume":"76","author":"Jia","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijbiomac.2026.152742_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1550158","article-title":"New strategies to enhance the efficiency and precision of drug discovery","volume":"16","author":"An","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.152742_bb0065","article-title":"Computer-aided drug discovery: from traditional simulation methods to language models and quantum computing","volume":"5","author":"Pei","year":"2024","journal-title":"Cell Rep. Phys. Sci."},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.152742_bb0070","doi-asserted-by":"crossref","first-page":"18633","DOI":"10.1021\/acs.jmedchem.4c02462","article-title":"Current status of computational approaches for small molecule drug discovery","volume":"67","author":"Xu","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152742_bb0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41746-024-01064-1","article-title":"To warrant clinical adoption, AI models require a multi-faceted implementation evaluation","volume":"7","author":"van de Sande","year":"2024","journal-title":"NPJ Digit. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152742_bb0080","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad422","article-title":"From intuition to AI: evolution of small molecule representations in drug discovery","volume":"25","author":"McGibbon","year":"2023","journal-title":"Brief. Bioinform."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152742_bb0085","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1097\/JS9.0000000000001289","article-title":"Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis","volume":"110","author":"Wu","year":"2024","journal-title":"Int. J. Surg. (London, England)"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.152742_bb0090","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s00044-024-03302-3","article-title":"Insights into computer-aided G-quadruplex prediction in the digital age","volume":"33","author":"Pramanik","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ijbiomac.2026.152742_bb0095","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.biochi.2018.06.024","article-title":"G-quadruplex virtual drug screening: a review","volume":"152","author":"Monsen","year":"2018","journal-title":"Biochimie"},{"issue":"000","key":"10.1016\/j.ijbiomac.2026.152742_bb0100","first-page":"11","article-title":"Cationic porphyrin TMPyP4 redox behaviour and interaction with nucleic acids: towards a new methodology for screening porphyrin-based anticancer drugs","volume":"462","author":"Manaia","year":"2023","journal-title":"Electrochim. Acta"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.152742_bb0105","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41419-024-07215-2","article-title":"Targeting G-quadruplex by TMPyP4 for inhibition of colorectal cancer through cell cycle arrest and boosting anti-tumor immunity","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.152742_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122481","article-title":"G-quadruplex ligands in cancer therapy: progress, challenges, and clinical perspectives","volume":"340","author":"Figueiredo","year":"2024","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152742_bb0115","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1093\/nar\/gkac151","article-title":"G-quadruplex inducer\/stabilizer pyridostatin targets SUB1 to promote cytotoxicity of a transplatinum complex","volume":"50","author":"Hou","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"26","key":"10.1016\/j.ijbiomac.2026.152742_bb0120","doi-asserted-by":"crossref","first-page":"11878","DOI":"10.1021\/jacs.2c04775","article-title":"Structural basis of pyridostatin and its derivatives specifically binding to G-quadruplexes","volume":"144","author":"Liu","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152742_bb0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s12967-025-06473-8","article-title":"The G-quadruplex ligand CX-5461: an innovative candidate for disease treatment","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152742_bb0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41588-023-01602-9","article-title":"The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells","volume":"56","author":"Koh","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijbiomac.2026.152742_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126068","article-title":"Novel phenanthrene imidazoles as telomeric G-quadruplex ligands trigger potent immunogenic cell death in triple-negative breast cancer","volume":"249","author":"Wang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.152742_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104074","article-title":"Synthesis, docking studies and anti-tumor activity of phenanthroimidazole derivatives as promising c-myc G-quadruplex DNA stabilizers","volume":"102","author":"Wu","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.152742_bb0145","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1080\/17568919.2024.2400982","article-title":"Benzimidazole-based small molecules as anticancer agents targeting telomeric G-quadruplex and inhibiting telomerase enzyme","volume":"16","author":"Elango","year":"2024","journal-title":"Future Med. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152742_bb0150","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/1535-7163.MCT-17-0834","article-title":"APTO-253 is a new addition to the repertoire of drugs that can exploit DNA BRCA1\/2 deficiency","volume":"17","author":"Tsai","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"22","key":"10.1016\/j.ijbiomac.2026.152742_bb0155","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1182\/blood.V128.22.1716.1716","article-title":"Inhibition of c-Myc by Apto-253 as an innovative therapeutic approach to induce cell cycle arrest and apoptosis in acute myeloid leukemia","volume":"128","author":"Zhang","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.152742_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-023-02168-6","article-title":"Novel biomolecules in targeted cancer therapy: a new approach towards precision medicine","volume":"40","author":"Kannampuzha","year":"2023","journal-title":"Med. Oncol."},{"issue":"29","key":"10.1016\/j.ijbiomac.2026.152742_bb0165","doi-asserted-by":"crossref","first-page":"16228","DOI":"10.1021\/jacs.3c05214","article-title":"Structure of the major G-quadruplex in the human EGFR oncogene promoter adopts a unique folding topology with a distinctive snap-back loop","volume":"145","author":"Liu","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"51","key":"10.1016\/j.ijbiomac.2026.152742_bb0170","doi-asserted-by":"crossref","first-page":"16048","DOI":"10.1021\/ja075710k","article-title":"Structural and thermodynamic studies of the interaction of distamycin A with the parallel quadruplex structure [d(TGGGGT)]\u2084","volume":"129","author":"Martino","year":"2007","journal-title":"J. Am. Chem. Soc."},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.152742_bb0175","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1021\/ja1003872","article-title":"Structural and conformational requisites in DNA quadruplex groove binding: another piece to the puzzle","volume":"132","author":"Cosconati","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"45","key":"10.1016\/j.ijbiomac.2026.152742_bb0180","doi-asserted-by":"crossref","first-page":"16336","DOI":"10.1021\/ja9063662","article-title":"Tandem application of virtual screening and NMR experiments in the discovery of brand new DNA quadruplex groove binders","volume":"131","author":"Cosconati","year":"2009","journal-title":"J. Am. Chem. Soc."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.152742_bb0185","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.3390\/ijms22158019","article-title":"Sebesty\u00e9n, rapamycin plus doxycycline combination affects growth arrest and selective autophagy-dependent cell death in breast cancer cells","volume":"22","author":"Dank\u00f3","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152742_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116918","article-title":"Erastin promotes random-pattern skin flaps survival by inducing mTORC1-TFEB mediated autophagy","volume":"177","author":"Chen","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2026.152742_bb0195","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2915019","article-title":"RSL3 drives ferroptosis through NF-\u03baB pathway activation and GPX4 depletion in glioblastoma","author":"Li","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152742_bb0200","first-page":"377","article-title":"Overcoming therapy resistance in EGFR-mutant lung cancer","volume":"2","author":"Passaro","year":"2021","journal-title":"Nat. Can."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152742_bb0205","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41571-024-00971-2","article-title":"The changing treatment landscape of EGFR-mutant non-small-cell lung cancer","volume":"22","author":"Zhou","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152742_bb0210","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/cmdc.201700747","article-title":"Design of modular G-quadruplex ligands","volume":"13","author":"Duarte","year":"2018","journal-title":"ChemMedChem"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152742_bb0215","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s12272-015-0640-5","article-title":"Role of computer-aided drug design in modern drug discovery","volume":"38","author":"Macalino","year":"2015","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2026.152742_bb0220","article-title":"CX-5461 inhibits cell proliferation and induces ferroptosis of colorectal cancer cells by inactivating Nrf2 pathway","volume":"135","author":"Chang","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ijbiomac.2026.152742_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109656","article-title":"Discovery of small-sized tris-aryl imidazoles as bifunctional ligands for c-Myc and KRAS G-quadruplexes","volume":"173","author":"Liu","year":"2026","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152742_bb0230","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1021\/acs.jmedchem.5c02600","article-title":"Novel tetrahydroxanthylium-based ligands targeting mitochondrial DNA G-quadruplex structures for concurrent induction of apoptosis and inhibition of autophagy in liver cancer","volume":"69","author":"Wang","year":"2026","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152742_bb0235","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.1021\/acs.jmedchem.4c00285","article-title":"Cycloplatinated (II) complex based on isoquinoline alkaloid elicits ferritinophagy-dependent ferroptosis in triple-negative breast cancer cells","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152742_bb0240","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1021\/acs.jmedchem.3c02127","article-title":"Exploring the dispersion and electrostatic components in arene\u2013arene interactions between ligands and G4 DNA to develop G4-ligands","volume":"67","author":"Andreasson","year":"2024","journal-title":"J. Med. Chem."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026026693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026026693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:52:33Z","timestamp":1783104753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026026693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":48,"alternative-id":["S0141813026026693"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152742","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the EGFR G-quadruplex DNA in liver cancer: Discovery of alkynyl-modified phenanthroimidazole derivatives as potent stabilizers","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152742"}}